ArticleNature communications2026

Proteomic characterization of intrahepatic cholangiocarcinoma identifies risk-stratifying subgroups and EIF4A1 as a therapeutic target.

Tilman Werner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.